Daniel C Danila

Daniel C Danila

UNVERIFIED PROFILE

Are you Daniel C Danila?   Register this Author

Register author
Daniel C Danila

Daniel C Danila

Publications by authors named "Daniel C Danila"

Are you Daniel C Danila?   Register this Author

36Publications

827Reads

17Profile Views

Clinical Validity of Detecting Circulating Tumor Cells by AdnaTest Assay Compared With Direct Detection of Tumor mRNA in Stabilized Whole Blood, as a Biomarker Predicting Overall Survival for Metastatic Castration-Resistant Prostate Cancer Patients.

Cancer J 2016 Sep/Oct;22(5):315-320

From the *Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center; †Department of Medicine, Weill Cornell Medical College; and Departments of ‡Laboratory Medicine and §Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000220DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108569PMC
August 2017

Alkaline phosphatase velocity predicts overall survival and bone metastasis in patients with castration-resistant prostate cancer.

Urol Oncol 2017 07 11;35(7):460.e21-460.e28. Epub 2017 Apr 11.

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2017.02.001DOI Listing
July 2017

A Pilot Study of a Multimodal Treatment Paradigm to Accelerate Drug Evaluations in Early-stage Metastatic Prostate Cancer.

Urology 2017 04 22;102:164-172. Epub 2016 Nov 22.

Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2016.10.044DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468169PMC
April 2017

Circulating tumor cell biomarker panel as an individual-level surrogate for survival in metastatic castration-resistant prostate cancer.

J Clin Oncol 2015 Apr 23;33(12):1348-55. Epub 2015 Mar 23.

Howard I. Scher, Glenn Heller, Daniel C. Danila, and Martin Fleisher, Memorial Sloan Kettering Cancer Center; Howard I. Scher and Daniel C. Danila, Weill Cornell Medical College; Xiaoyu Jia, Columbia University, New York, NY; Arturo Molina, Janssen Research & Development, Menlo Park; Weimin Peng, Janssen Research & Development, Los Angeles; Thian Kheoh, Janssen Research & Development, San Diego, CA; Gerhardt Attard, Shahneen K. Sandhu, David Olmos, Ruth Riisnaes, and Johann S. de Bono, Institute of Cancer Research; Gerhardt Attard, Shahneen K. Sandhu, David Olmos, and Johann S. de Bono, Royal Marsden Hospital, Sutton, United Kingdom; Robert McCormack, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski and Marc Buyse, International Drug Development Institute, Louvain-la-Neuve, Belgium.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/03/23/JCO.2014.55
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.55.3487
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.55.3487DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397279PMC
April 2015

Organoid cultures derived from patients with advanced prostate cancer.

Cell 2014 Sep 4;159(1):176-187. Epub 2014 Sep 4.

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2014.08.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237931PMC
September 2014

Analytic and clinical validation of a prostate cancer-enhanced messenger RNA detection assay in whole blood as a prognostic biomarker for survival.

Eur Urol 2014 Jun 26;65(6):1191-7. Epub 2013 Jul 26.

Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2013.07.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113474PMC
June 2014

Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer.

J Clin Oncol 2013 Oct 3;31(28):3525-30. Epub 2013 Sep 3.

Dana E. Rathkopf, Michael J. Morris, Josef J. Fox, Daniel C. Danila, Susan F. Slovin, Mithat Gönen, Martin Fleisher, Steven M. Larson, Charles L. Sawyers, and Howard I. Scher, Memorial Sloan-Kettering Cancer Center; Dana E. Rathkopf, Michael J. Morris, Josef J. Fox, Daniel C. Danila, Susan F. Slovin, Steven M. Larson, and Howard I. Scher, Weill Cornell Medical College, New York, NY; Jeffrey H. Hager, Peter J. Rix, Edna Chow Maneval, and Isan Chen, Aragon Pharmaceuticals, San Diego, CA; and Charles L. Sawyers, Howard Hughes Medical Institute, Chevy Chase, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.50.1684DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782148PMC
October 2013

Monitoring the clinical outcomes in advanced prostate cancer: what imaging modalities and other markers are reliable?

Semin Oncol 2013 Jun;40(3):375-92

Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2013.04.008DOI Listing
June 2013

Circulating tumors cells as biomarkers: progress toward biomarker qualification.

Cancer J 2011 Nov-Dec;17(6):438-50

Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0b013e31823e69acDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3985131PMC
June 2012

Circulating tumor cells as biomarkers in prostate cancer.

Clin Cancer Res 2011 Jun;17(12):3903-12

Genitourinary Oncology Service, Department of Medicine and Department of Clinical Laboratories, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-2650DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743247PMC
June 2011

Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer.

Clin Cancer Res 2009 Mar 10;15(6):2091-7. Epub 2009 Mar 10.

Molecular Cytogenetics Core Laboratory, Department of Medicine, Memorial Sloan-kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-2036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875199PMC
March 2009

Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer.

Clin Cancer Res 2007 Dec;13(23):7053-8

Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-07-1506DOI Listing
December 2007

A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells.

J Clin Endocrinol Metab 2003 Nov;88(11):5119-26

Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114,USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2003-030222DOI Listing
November 2003

Overexpression of wild-type activin receptor alk4-1 restores activin antiproliferative effects in human pituitary tumor cells.

J Clin Endocrinol Metab 2002 Oct;87(10):4741-6

Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2002-020527DOI Listing
October 2002

Loss of expression of GADD45 gamma, a growth inhibitory gene, in human pituitary adenomas: implications for tumorigenesis.

J Clin Endocrinol Metab 2002 Mar;87(3):1262-7

Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jcem.87.3.8315DOI Listing
March 2002